TDRD15: A Potential Drug Target and Biomarker (G100129278)

Target Name: TDRD15

NCBI ID: G100129278

TDRD15

Other Name(s): Tudor domain-containing protein 15 | TDR15_HUMAN | tudor domain-containing protein 6-like | tudor domain containing 15 | Tudor domain containing 15

TDRD15: A Potential Drug Target and Biomarker

TDRD15, short for T-cell receptor activator 15, is a protein that is expressed in T cells, a type of white blood cell that plays a crucial role in the immune system. TDRD15 has been identified as a potential drug target and biomarker due to its unique structure and the studies that have shown its ability to interact with certain drugs.

The immune system is a vital component of the body that helps protect it from infection and disease. T cells, in particular, are important for cell-mediated immunity, as they recognize and destroy foreign substances like viruses and bacteria. TDRD15 is a protein that is expressed in T cells and has been shown to play a role in this process.

One of the key functions of TDRD15 is its ability to interact with certain drugs. For example, studies have shown that TDRD15 can interact with the drug paclitaxel, which is used to treat various cancers. In these studies, TDRD15 was shown to be able to bind to paclitaxel and enhance its effects. This suggests that TDRD15 may be a useful biomarker for monitoring the effectiveness of paclitaxel and other drugs.

Another potential use of TDRD15 as a drug target is its role in the regulation of cellular processes. TDRD15 has been shown to play a role in the regulation of cell division and the signaling of cell-cell interactions. This suggests that TDRD15 may be a useful target for drugs that are used to inhibit cell division or enhance the signaling of cell-cell interactions.

In addition to its potential as a drug target, TDRD15 has also been shown to be a potential biomarker for certain diseases. For example, studies have shown that TDRD15 is overexpressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that TDRD15 may be a useful biomarker for these diseases and can be used to identify new treatments.

Overall, TDRD15 is a protein that has the potential to be a drug target and biomarker. Its unique structure and ability to interact with certain drugs make it an attractive target for researchers to investigate further. Further studies are needed to fully understand the role of TDRD15 in the immune system and its potential as a drug.

Protein Name: Tudor Domain Containing 15

The "TDRD15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TDRD15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets